NuBatt Pte. Ltd.
Nuclear Technology Company
Private Placement Memorandum
Target Raise
$119M
Equity Offered
30%
Pre-Money Valuation
~$397M
Investment Highlights
Revolutionary Technology
Four nuclear voltaic platforms converting radioactive decay directly to electricity with 50+ year operational life
Multi-Revenue Model
Six diversified revenue streams: nuclear batteries, medical isotopes, industrial isotopes, waste recycling, SiC wafers, licensing
Validated & Protected
DSO Singapore feasibility study completed. 9 patent families with perpetual, irrevocable license
Massive Market Opportunity
$10B+ combined addressable market across defence, medical, industrial, and semiconductor sectors
Defence Entry Point
Established relationship with DSO National Laboratories Singapore providing validated customer pathway
Clear Growth Path
$50M revenue in 2027 scaling to $2.8B by 2031. IPO target 2030 at $10B+ valuation
This Memorandum is confidential and intended solely for authorized recipients. Do not distribute without written consent from NuBatt Pte. Ltd.
NuBatt Pte. Ltd. • 16 Raffles Quay, #41-01 Hong Leong Building, Singapore 048581